ArticleMolecular therapy. Oncology2025

Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort study.

Rui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.